Tenofovir Monotherapy in Patients With Chronic Hepatitis B Patients Who Had Achieved Complete Viral Suppression on Entecavir Plus Tenofovir

Clinical trial NCT03236610 · UNKNOWN

Trial details

NCT number: NCT03236610
Sponsor: Uijeongbu St. Mary Hospital
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Proportion of Patients With a Sustained Virological Response (Serum HBV DNA <20 IU/mL) at Week 48

Start date: 2016-01-01
Primary completion: 2018-06-30
Enrollment: 112

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.